PMID: 9949452Feb 9, 1999

Plasma middle mass molecules in viral hepatitis

Terapevticheskiĭ arkhiv
B S NagoevI A Kimova


The study of the level of middle mass molecules (MMM) in blood plasma of patients in different periods of viral hepatitis; their relation to some routine markers of viral hepatitides; appropriateness of MMM test in differential diagnosis with other jaundices. Plasma MMM content was measured in 123 patients aged 17-65. 28 of them had mild form of viral hepatitis, 56 had moderately severe and severe hepatitis, 39 had jaundice of other etiology. Healthy donors with MMM levels 1.18 +/- 0.02 optic units served as control. Computer correlation analysis discovered a rise in blood levels of MMM in the phase of jaundice development, a fall in the phase of the disease peak, rise again in the phase of jaundice attenuation and normalization in convalescents. The changes were small in mild disease, great in moderate and grave disease. In the absence of intoxication MMM made up 1.27 +/- 0.0.02 OU, in dramatic intoxication MMM level rose to 1.47 +/- 0.04 OU (p < 0.05). Correlation was not noted between MMM content and conventional markers of viral hepatitides. There was no rise in concentration of MMM in non-viral jaundice. MMM concentrations in plasma in viral hepatitides can be used as a prognostic and differential-diagnostic sign.

Related Concepts

Yellow Skin or Eyes (Symptom)
Computer Assisted Diagnosis
Bilirubin, (4E,15E)-Isomer
Differential Diagnosis
Jaundice, Hemolytic
In Blood

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.